Stockreport

Blackstone invests $2 billion in Alnylam, boosting gene-silencing drug development [Yahoo! Finance News]

Blackstone Inc.  (BX) 
Last blackstone inc. earnings: 4/23 06:56 am Check Earnings Report
PDF Reuters) - Blackstone Group Inc said on Monday it invested $2 billion in Alnylam Pharmaceuticals Inc through an equity-and-debt deal, giving the drugmaker a financial [Read more]